title: Management of hereditary angioedema.
abstract: Hereditary angioedema is characterised by unpredictable, painful and potentially life-threatening oedema. Recently, some C1 inhibitors have been approved for self-administration and/or routine prevention, enabling patients to be proactive in managing their disease and reducing the burden of illness. This article discusses the effect of these advances from a specialist nurse's perspective.
authors.affiliation: The Royal London Hospital, London. john.dempster@bartshealth.nhs.uk
authors.forename: John
authors.initials: J
authors.lastname: Dempster
mesh_terms: D054179:Angioedemas, Hereditary / Q000188:drug therapy / Q000235:genetics / Q000451:nursing*; D050718:Complement C1 Inhibitor Protein / Q000008:administration & dosage / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D007262:Infusions, Intravenous; D024802:Nurse's Role; D012646:Self Administration; D006113:United Kingdom
chemical_list: D050718:Complement C1 Inhibitor Protein